SUNNYVALE, Calif., Oct. 21, 2019 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Suzanne Winter has joined the company as Senior Vice President, Chief Commercial Officer effective October 21, 2019. Ms. Winter will have global responsibility for the commercial function reporting to

MALVERN, Pa., Oct. 21, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today it will ring the Nasdaq Closing Bell on October 22

OAKLAND, CA and TORONTO, Oct. 21, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company") (CSE: HBOR), today announced that the U.S. Tax Court has issued a final decision under Tax Court Rule 155 on the income tax deficiency for Patients Mutual Assistance Collective Corporation ("PMACC"), the Company's 100% owned subsidiary an

ANN ARBOR, Mich., Oct. 21, 2019 /PRNewswire/ -- Domino's (NYSE: DPZ), the largest pizza company in the world based on global retail sales, is ready to raise funds for St. Jude Children's Research Hospital® online and in stores across the country. The campaign, which begins today and runs for 11 weeks through Jan

MARINA DEL REY, Calif., Oct. 21, 2019 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it has received a Research and Development (R&D) Tax Incentive cash rebate of USD

CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of John T. Potts, MD, DSc, to its Board of Directors. Dr. Potts' distinguished, five-decade ca

BOSTON, Oct. 21, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that the Company will host a Cystic Fibrosis Summit. The event, ti

DUBLIN, Oct. 21, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a clinical research collaboration with Fred Hutchinson Cancer Research Center (

BILLERICA, Mass., Oct. 21, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2019 financial results on Thursday, October 31, 2019, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results a

IRVINE, Calif., Oct. 21, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced select unaudited preliminary financial results for the third quarter ended September 30, 2019.